Arboretum LifeSciences
PrivateCompany Overview
Arboretum LifeSciences is a biotechnology company that developed a platform for precision medicine and genetic testing programs for cardiovascular disease, cancer, and metabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arboretum LifeSciences Comparables
Compare Arboretum LifeSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nest Genomics | 82% | |
| Helix | 78% | |
| Allelica, Inc. | 74% | |
Arboretum LifeSciences Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2025
Grew 100% QoQ from 3 to 6 employees.
Arboretum LifeSciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arboretum LifeSciences's valuation, stock price, and market status.